The sleep apnea treatment and semiconductor industries are advancing rapidly to address critical health and technology needs. Vivos Therapeutics, Inc. (VVOS) leads in developing innovative treatments for obstructive sleep apnea (OSA), focusing on non-invasive and patient-friendly solutions. Silicon Laboratories Inc. (SLAB) is a major player in the semiconductor sector, providing integrated circuits and software solutions […]
Read MoreVivos Therapeutics, Inc. (VVOS) focuses on providing innovative, non-invasive treatments for sleep apnea and related health conditions. The company’s flagship product, the Vivos System, is a suite of oral appliances designed to help patients achieve better airflow and breathing patterns, reducing the impact of obstructive sleep apnea. Unlike traditional methods like CPAP machines, Vivos offers […]
Read MoreAxogen, Inc. (AXGN) focuses on creating advanced solutions for nerve repair and regeneration. As a leader in the field of nerve care, Axogen addresses injuries and conditions that can disrupt a patient’s ability to perform everyday tasks. The company’s portfolio includes surgical products designed to repair damaged peripheral nerves and restore functionality. These include Avance […]
Read MoreIntra-Cellular Therapies, Inc. (ITCI) is at the forefront of innovative treatments for serious psychiatric and neurological disorders. Specializing in mental health solutions, ITCI develops advanced therapeutics that address conditions such as schizophrenia, bipolar depression, and other mood disorders. Its flagship product, CAPLYTA (lumateperone), is an FDA-approved treatment for schizophrenia and bipolar depression. Designed to improve […]
Read More